vs
ENANTA PHARMACEUTICALS INC（ENTA）与REDWOOD TRUST INC（RWT）财务数据对比。点击上方公司名可切换其他公司
REDWOOD TRUST INC的季度营收约是ENANTA PHARMACEUTICALS INC的1.4倍（$25.9M vs $18.6M），REDWOOD TRUST INC净利率更高（77.2% vs -64.1%，领先141.4%），ENANTA PHARMACEUTICALS INC同比增速更快（9.8% vs -6.1%），过去两年ENANTA PHARMACEUTICALS INC的营收复合增速更高（4.5% vs -41.0%）
Enanta制药是一家临床阶段生物技术企业，专注于研发针对乙型肝炎病毒、呼吸道合胞病毒、新冠病毒等传染性疾病的创新抗病毒疗法，与全球制药伙伴合作推进小分子候选药物管线，满足未被覆盖的临床需求。
Redwood Trust Inc是总部位于美国的专业房地产投资信托公司，主营住宅与商业抵押贷款、抵押贷款支持证券及房地产信贷类资产的投资管理，核心业务覆盖住宅抵押贷款发放、商业地产信贷和投资服务，客户以机构投资者和房地产市场参与者为主。
ENTA vs RWT — 直观对比
营收规模更大
RWT
是对方的1.4倍
$18.6M
营收增速更快
ENTA
高出15.9%
-6.1%
净利率更高
RWT
高出141.4%
-64.1%
两年增速更快
ENTA
近两年复合增速
-41.0%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $18.6M | $25.9M |
| 净利润 | $-11.9M | $20.0M |
| 毛利率 | — | — |
| 营业利润率 | -60.5% | — |
| 净利率 | -64.1% | 77.2% |
| 营收同比 | 9.8% | -6.1% |
| 净利润同比 | 46.4% | 402.6% |
| 每股收益（稀释后） | $-0.42 | $0.11 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ENTARWT
| Q4 25 | $18.6M | $25.9M | ||
| Q3 25 | $15.1M | $15.0M | ||
| Q2 25 | $18.3M | $13.8M | ||
| Q1 25 | $14.9M | $27.9M | ||
| Q4 24 | $17.0M | $27.6M | ||
| Q3 24 | $14.6M | $25.5M | ||
| Q2 24 | $18.0M | $67.4M | ||
| Q1 24 | $17.1M | $74.5M |
净利润ENTARWT
| Q4 25 | $-11.9M | $20.0M | ||
| Q3 25 | $-18.7M | $-7.7M | ||
| Q2 25 | $-18.3M | $-98.5M | ||
| Q1 25 | $-22.6M | $16.1M | ||
| Q4 24 | $-22.3M | $-6.6M | ||
| Q3 24 | $-28.8M | $14.8M | ||
| Q2 24 | $-22.7M | $15.5M | ||
| Q1 24 | $-31.2M | $30.3M |
营业利润率ENTARWT
| Q4 25 | -60.5% | — | ||
| Q3 25 | -121.6% | -9.0% | ||
| Q2 25 | -103.2% | -679.0% | ||
| Q1 25 | -164.3% | 80.2% | ||
| Q4 24 | -138.8% | -1.3% | ||
| Q3 24 | -204.4% | 86.1% | ||
| Q2 24 | -134.6% | 30.3% | ||
| Q1 24 | -192.1% | 41.3% |
净利率ENTARWT
| Q4 25 | -64.1% | 77.2% | ||
| Q3 25 | -123.6% | -51.4% | ||
| Q2 25 | -99.7% | -712.0% | ||
| Q1 25 | -151.7% | 57.8% | ||
| Q4 24 | -131.4% | -24.0% | ||
| Q3 24 | -197.3% | 58.1% | ||
| Q2 24 | -126.1% | 23.0% | ||
| Q1 24 | -182.7% | 40.6% |
每股收益（稀释后）ENTARWT
| Q4 25 | $-0.42 | $0.11 | ||
| Q3 25 | $-0.88 | $-0.08 | ||
| Q2 25 | $-0.85 | $-0.76 | ||
| Q1 25 | $-1.06 | $0.10 | ||
| Q4 24 | $-1.05 | $-0.08 | ||
| Q3 24 | $-1.36 | $0.09 | ||
| Q2 24 | $-1.07 | $0.10 | ||
| Q1 24 | $-1.47 | $0.21 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $37.4M | $255.7M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $126.6M | $982.6M |
| 总资产 | $329.5M | $23.7B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资ENTARWT
| Q4 25 | $37.4M | $255.7M | ||
| Q3 25 | $32.3M | $226.3M | ||
| Q2 25 | $44.8M | $302.0M | ||
| Q1 25 | $60.2M | $259.9M | ||
| Q4 24 | $84.3M | $245.2M | ||
| Q3 24 | $37.2M | $253.7M | ||
| Q2 24 | $35.8M | $275.6M | ||
| Q1 24 | $63.5M | $275.4M |
总债务ENTARWT
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | $1.7B |
股东权益ENTARWT
| Q4 25 | $126.6M | $982.6M | ||
| Q3 25 | $64.7M | $999.0M | ||
| Q2 25 | $79.3M | $1.1B | ||
| Q1 25 | $93.5M | $1.2B | ||
| Q4 24 | $111.8M | $1.2B | ||
| Q3 24 | $128.8M | $1.2B | ||
| Q2 24 | $148.9M | $1.2B | ||
| Q1 24 | $166.1M | $1.2B |
总资产ENTARWT
| Q4 25 | $329.5M | $23.7B | ||
| Q3 25 | $280.7M | $22.6B | ||
| Q2 25 | $301.0M | $21.3B | ||
| Q1 25 | $323.0M | $19.9B | ||
| Q4 24 | $348.6M | $18.3B | ||
| Q3 24 | $376.7M | $18.4B | ||
| Q2 24 | $398.8M | $16.5B | ||
| Q1 24 | $413.6M | $15.1B |
负债/权益比ENTARWT
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | 1.39× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-11.7M | $-10.1B |
| 自由现金流经营现金流 - 资本支出 | $-11.8M | — |
| 自由现金流率自由现金流/营收 | -63.6% | — |
| 资本支出强度资本支出/营收 | 0.8% | — |
| 现金转化率经营现金流/净利润 | — | -504.15× |
| 过去12个月自由现金流最近4个季度 | $-18.5M | — |
8季度趋势，按日历期对齐
经营现金流ENTARWT
| Q4 25 | $-11.7M | $-10.1B | ||
| Q3 25 | $-6.5M | $-2.7B | ||
| Q2 25 | $17.5M | $-2.1B | ||
| Q1 25 | $-13.5M | $-2.0B | ||
| Q4 24 | $-16.8M | $-5.9B | ||
| Q3 24 | $-10.4M | $-2.1B | ||
| Q2 24 | $-14.8M | $-2.0B | ||
| Q1 24 | $-28.6M | $-954.2M |
自由现金流ENTARWT
| Q4 25 | $-11.8M | — | ||
| Q3 25 | $-7.9M | — | ||
| Q2 25 | $17.4M | — | ||
| Q1 25 | $-16.0M | — | ||
| Q4 24 | $-25.5M | — | ||
| Q3 24 | $-19.4M | — | ||
| Q2 24 | $-21.3M | — | ||
| Q1 24 | $-30.3M | — |
自由现金流率ENTARWT
| Q4 25 | -63.6% | — | ||
| Q3 25 | -52.5% | — | ||
| Q2 25 | 94.7% | — | ||
| Q1 25 | -107.4% | — | ||
| Q4 24 | -150.6% | — | ||
| Q3 24 | -132.5% | — | ||
| Q2 24 | -118.6% | — | ||
| Q1 24 | -177.5% | — |
资本支出强度ENTARWT
| Q4 25 | 0.8% | — | ||
| Q3 25 | 9.6% | — | ||
| Q2 25 | 0.8% | — | ||
| Q1 25 | 17.0% | — | ||
| Q4 24 | 51.6% | — | ||
| Q3 24 | 61.3% | — | ||
| Q2 24 | 36.4% | — | ||
| Q1 24 | 9.8% | — |
现金转化率ENTARWT
| Q4 25 | — | -504.15× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | -120.92× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | -140.86× | ||
| Q2 24 | — | -126.56× | ||
| Q1 24 | — | -31.53× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
